Adler Amanda, Bennett Peter, Colagiuri Chair Stephen, Gregg Edward, Narayan K M Venkat, Inês Schmidt Maria, Sobngwi Eugene, Tajima Naoko, Tandon Nikhil, Unwin Nigel, Wild Sarah, Yudkin John, Levitt Naomi, Mohan Viswanathan, Montgomery Sarah, Nyirenda Moffat J, Tuomilehto Jaakko, Den Boon Saskia, Hocking Samantha
Addenbrooke's Hospital, Cambridge, UK.
Phoenix Epidemiology & Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, USA.
Diabetes Res Clin Pract. 2021 Jul 31:108972. doi: 10.1016/j.diabres.2021.108972.
Executive Summary This document updates the 1999 World Health Organization (WHO) classification of diabetes. It prioritizes clinical care and guides health professionals in choosing appropriate treatments at the time of diabetes diagnosis, and provides practical guidance to clinicians in assigning a type of diabetes to individuals at the time of diagnosis. It is a compromise between clinical and aetiological classification because there remain gaps in knowledge of the aetiology and pathophysiology of diabetes. While acknowledging the progress that is being made towards a more precise categorization of diabetes subtypes, the aim of this document is to recommend a classification that is feasible to implement in different settings throughout the world. The revised classification is presented in Table 1. Unlike the previous classification, this classification does not recognize subtypes of type 1 diabetes and type 2 diabetes and includes new types of diabetes ("hybrid types of diabetes" and "unclassified diabetes").
执行摘要 本文件更新了1999年世界卫生组织(WHO)的糖尿病分类。它将临床护理作为优先事项,并指导卫生专业人员在糖尿病诊断时选择合适的治疗方法,同时为临床医生在诊断时为个体确定糖尿病类型提供实用指导。这是临床分类和病因分类之间的一种折衷,因为糖尿病的病因学和病理生理学知识仍存在空白。在承认朝着更精确的糖尿病亚型分类取得进展的同时,本文件的目的是推荐一种在世界各地不同环境中都可行实施的分类方法。修订后的分类见表1。与之前的分类不同,本分类不认可1型糖尿病和2型糖尿病的亚型,而是包括新型糖尿病(“混合型糖尿病”和“未分类糖尿病”)。